VIRVir Biotechnology, Inc.
$11.71+126% 1Y
$11.71
$5.1252 weeks$11.78
Is the price fair?
What VIR's price assumes
Vir Biotechnology, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 24.3× revenue.
24.3
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.18
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 17.6
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 2.18
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 17.6
- Market capitalisation
- $1.67B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks